Compare Quest Diagnostics Inc (DGX) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Vipshop Holdings Ltd - ADR — how do they compare? Quest Diagnostics Inc trades at $230.72 (market cap $25.06B), while Vipshop Holdings Ltd - ADR trades at $12.71 (market cap $6.07B). The key difference: Quest Diagnostics Inc is far larger — about 4.1× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.86%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Vipshop Holdings Ltd - ADR for 49 Days on average.
| DGX | VIPS | |
|---|---|---|
Market Cap | $25.06B | $6.07B |
Volume | 927,361 | 3,134,219 |
Sector | Health | Consumer Cyclical |
52-Week High | $247.45 | $20.29 |
52-Week Low | $173.49 | $12.09 |
Typical Hold Time | 56 Days | 49 Days |
Enterprise Value | $30.82B | $2.90B |
Dividend Yield | 1.52% | 4.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.03% with consistent earnings beats in recent quarters. The stock shows bearish technical signals despite strong fundamentals including 9.19% net margins and 14.35% ROE. Recent developments include a partnership with Apple Health app and concerns about Medicare reimbursement cuts affecting future revenue streams.
The outlook remains cautiously optimistic with a $250 consensus price target representing 8.3% upside potential. Key opportunities include growth in advanced diagnostics and consumer testing demand, while risks center on Medicare payment reductions and competitive pressures in the diagnostic services market.
Vipshop Holdings trades at $12.77, showing modest daily gains of 0.16%. The stock presents compelling value with a P/E of 4.12 and P/S of 0.41, significantly below sector averages. Recent earnings showed mixed results with Q2 2026 missing expectations, but the company maintains strong profitability with 9.82% net margins and 24.44% ROE. Technical indicators show a bullish overall signal despite recent price consolidation near key support levels.
The investment case balances deep valuation discounts against growth challenges. Analyst consensus targets $16.17 (26% upside) with 54% buy ratings, though recent earnings misses and consumer spending concerns warrant caution. Strong cash generation and shareholder returns provide downside protection, making VIPS attractive for value investors despite near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
